Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature

Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature

Wiskott-Aldrich syndrome (WAS) is characterized by eczema, recurrent infections and microthrombocytopenia, with the latter being the most consistent finding in the course of the disease. The present case report describes a pediatric patient with WAS and severe bleeding phenotype resulting from a ver...

Full description

Bibliographic Details
Main Authors: Alkistis Adramerina, Nancy Chainoglou, Stamatia Theodoridou, Aikaterini Teli, Marina Economou
Format: Article
Language:English
Published: The Korean Society of Pediatric Hematology-Oncology 2022-04-01
Series:Clinical Pediatric Hematology-Oncology
Subjects:
wiskott-aldrich syndrome
thrombocytopenia
thrombopoietin receptor agonists
eltrombopag
recombinant activated factor vii
Online Access:http://journaleditor.inforang.com/journal/view.html?doi=10.15264/cpho.2022.29.1.12

Internet

http://journaleditor.inforang.com/journal/view.html?doi=10.15264/cpho.2022.29.1.12

Similar Items